Voting Results pursuant to clause 44(3) of SEBI (LODR) Regulations, 2015 and Scrutinizer''s report for 40th AGM of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Limited held its 40th Annual General Meeting on September 9, 2025 via video conferencing. All four resolutions tabled at the meeting were passed with 100% votes in favour and no votes against. The resolutions covered: (1) adoption of audited financial statements for FY ended March 31, 2025, (2) re-appointment of Mr. Rishikesh Thakur as director (retiring by rotation), (3) ratification of cost auditor remuneration for FY 2025-2026, and (4) re-appointment of Mrs. Rachna Manav Ghai as Woman Independent Director (special resolution). Total voting participation was 50.56% (2,245,032 out of 4,440,568 outstanding shares), with 33 members voting electronically. The company has 6,166 shareholders on record.
This is a routine procedural filing confirming all AGM resolutions passed unanimously. There is no material impact on shareholders or stock price — no special dividends, fund raises, or strategic decisions were approved. The unanimous approval with zero dissent reflects smooth governance with no contentious items on the agenda.